Reporting to Jeffrey Burbank, CEO of NxStage, Turk will continue to manage the company’s North American commercial teams across the company’s three markets (Home, Critical Care, and In-Center) and will be responsible for driving company’s worldwide product portfolio.
Before joining NxStage, Turk served as director of New Business Development at Boston Scientific and prior to this, he was one of the leaders of McKinsey & company’s Midwest Health Care and Biotechnology Practice as a senior engagement manager in the firm’s Chicago Office.
NxStage CEO Jeffrey Burbank said Joe has been a driving force behind the company’s ability to successfully execute against its strategic initiatives and achieve its goals.
"As the scale of our business increases, Joe’s exceptional track record as a multi-faceted operating executive will be a great asset to our growth initiatives across all three of our markets," Burbank said.
Turk said he was privileged to have worked with such a talented team in achieving their milestones to date.
"I am proud of this recognition and I look forward to continuing to deliver value to our patients, customers, partners, and all of our stakeholders," Turk said.
